Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells.
Guo Y, Wang H, Liu S, Zhang X, Zhu X, Huang L, Zhong W, Guan L, Chen Y, Xiao M, Ou L, Yang J, Chen X, Huang AC, Mitchell T, Amaravadi R, Karakousis G, Miura J, Schuchter L, Flowers A, Zheng Q, Mou H, Gimotty P, Herlyn M, Guo W, Xu X.
Guo Y, et al. Among authors: wang h.
Sci Adv. 2025 Jan 17;11(3):eadp9009. doi: 10.1126/sciadv.adp9009. Epub 2025 Jan 15.
Sci Adv. 2025.
PMID: 39813334